Corvus Pharmaceuticals Inc (NASDAQ:CRVS) Has Recovered 41.01% So Far, But Another -77.53% Loss Is Possible.
Corvus Pharmaceuticals Inc (NASDAQ:CRVS)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 1.11. At the close of